baber/WOPTO huggingface dataset:
Patent EP-2325807-B2 (EP)
Inventor: VAN HAPEREN PETER
IPC: G07B15/06
Filed: 2009-11-23
Granted: 2022-04-27
Abstract: The method involves providing a location data record (mi) of toll road geo objects (o-11) from the local proximity (U-1) of a beacon (3). A road toll system (1) comprises a toll center (2) having a vehicle unit (4). The location data record is received from the beacon, when the vehicle unit is arranged in the reception area (S-1) of the beacon. Independent claims are also included for: (1) a vehicle equipment for a road toll system; (2) a beacon for a road toll system; and (3) a control instrument for a road toll system.
Patent EP-0469673-B2 (EP)
Inventor: GELISSEN FRANCISCUS WILHELMUS
IPC: B29C48/05
Filed: 1991-07-23
Granted: 2002-05-02
Abstract: Process for the production of a continuous object of a thermosetting polymer by polymerizing in a sheath the corresponding monomer, the monomer being injected in liquid form into the sheath in the plane of the die opening or immediately beyond it during the extrusion in continuous form of the sheath.
Patent EP-0556293-B2 (EP)
Inventor: MASSIRIO SERGIO
IPC: C07B61/00
Filed: 1991-10-16
Granted: 1999-06-30
Abstract: PCT No. PCT/US91/07666 Sec. 371 Date Jan. 24, 1992 Sec. 102(e) Date Jan. 24, 1992 PCT Filed Oct. 16, 1991 PCT Pub. No. WO92/07812 PCT Pub. Date May 14, 1992.A process for preparing bisphenol fluorene products which comprises reacting fluorenone with a phenol compound in the presence of an acidic condensing agent in a solution of an organic liquid wherein the bisphenol fluorene compound is insoluble and recovering the obtained bisphenol fluorene product from the reaction mixture.
Patent EP-0562035-B2 (EP)
Inventor: TAPPAN JAMES E
IPC: C23C16/513
Filed: 1991-12-11
Granted: 2001-09-05
Abstract: Procédé de régulation de la qualité du dépôt de surfaces de visée et cible dans un appareil de dépôt chimique en phase vapeur activée au plasma. L'invention concerne également un appareil de régulation de la qualité du dépôt de surfaces de visée et cible dans un appareil de dépôt chimique en phase vapeur activée au plasma. L'appareil comprend un écran à plasma (6) doté d'une surface de visée (10) et d'une cible de plasma (7) comportant une surface cible. La surface de visée (10) définit un alésage (9) à travers l'écran à plasma (6) et n'est pas en contact direct avec un courant de plasma, tel que de l'oxygène, passant de la chambre de plasma (2), par l'intermédiaire de l'alésage (9), dans une chambre de réaction (3). Un échantillon à semiconducteur est monté sur un support (5) dans la chambre de réaction (3). La surface cible entoure l'échantillon. Les surfaces de visée et cible (10) sont maintenues à une température constante par circulation d'un milieu fluide dans les passages de fluide (11) se trouvant dans l'écran à plasma (6) et la cible de plasma (7). Ladite cible de plasma (7) peut comprendre une plaque amovible (33) sur une face de laquelle se trouve la surface cible. L'écran à plasma peut comprendre un anneau à gaz amovible (24) destiné à éjecter du gaz tel que SiH4 dans l'alésage.
Patent EP-0733614-B2 (EP)
Inventor: FORAT GERARD
IPC: C07C29/38
Filed: 1996-03-22
Granted: 2010-01-13
Abstract: Nucleophilic reactant used for grafting a substd. difluoromethyl gp. onto an electrophilic cpd., comprises: (a) a fluorocarboxylic acid of formula Ea-CF2-COOH where Ea is electron-attracting atom or gp. at least partially salted by organic or mineral cation; and (b) a polar aprotic solvent. The content of potentially-free portions present in different components (i.e. impurities) is at most, equal to half initial molar concn. of the fluorocarboxylic acid. Also claimed is the method of synthesis of a deriv. incorporating the difluoromethylene gp. comprising: (i) reacting an electrophilic cpd. with the above reagent; and (ii) heating the mixt. at 100-200 deg.C for 1/2 hr. to one day.
Patent EP-0911342-B2 (EP)
Inventor: YAMAGUCHI KYOJI
IPC: A61K38/17
Filed: 1998-04-15
Granted: 2013-05-22
Abstract: A novel protein which binds to Osteoclastogenesis Inhibitory Factor (OCIF-binding molecule; OBM), a process for preparing the same, DNA encoding said protein, a protein having an amino acid sequence encoded by this DNA, a method for producing said protein by genetic engineering technique, and a pharmaceutical composition containing said protein.  Screening methods for a substance for controlling expression of said protein using said protein and the DNA, a substance which inhibits or modulates the biological activity of said protein, or a receptor which transmits the action of said protein through binding to said protein, the substance obtained by the screening methods, and a pharmaceutical composition which contains this substance.  An antibody for said protein, a process for preparing the same, a measuring method of said protein using the antibody, and a medicine comprising this antibody.
Patent JP-2656035-B2 (JP)
IPC: C07D261/02
Filed: 1987-05-08
Granted: 1997-09-24
Abstract: The present invention is 3,5-substituted, isoxazoles, pyrazoles, isothiazoles, and analogs thereof having 5-lipoxygenase or cyclooxygenase inhibiting activity or as a sunscreen.
Patent JP-3093441-B2 (JP)
IPC: F28D15/02
Filed: 1992-04-28
Granted: 2000-10-03
Abstract: PURPOSE:To provide a heat sink for an electronic apparatus in which a large quantity of heat can be dissipated without contact heat resistance between a heat pipe and a heat dissipating fin and which has low manufacturing cost. CONSTITUTION:A heat pipe is formed of a roll bond panel 1 in which predetermined passages 8, 8 in which operating fluids flow therein are formed. On the other hand, heat dissipating fin units 20, 20' are formed integrally with heat dissipating fins 21, 22 and a board 23. The panel 2 and the board 23 of the units 20, 20' are integrated by brazing through a brazing sheet.
Patent JP-4573374-B2 (JP)
IPC: H01S5/02
Filed: 1999-05-21
Granted: 2010-11-04
Abstract: PROBLEM TO BE SOLVED: To provide a method of manufacturing a semiconductor laser device having favorable productivity in a chip dividing process without deterioration of thermal resistance. SOLUTION: This method of manufacturing a semiconductor laser device has steps of forming a multilayer metal film successively composed of a first metal film 105 and a second metal film 106, having a thickness through which a wafer surface structure can be confirmed from the backside of the wafer on the bottom surface of a wafer substrate for a semiconductor light emitting element provided with a transparent substrate 101 and a semiconductor laminate 102 provided thereon; performing alignment by recognizing the wafer surface structure from the wafer backside to form dividing grooves on the wafer backside and divide the wafer, thereby forming semiconductor light emitting element chips; loading a semiconductor light emitting element chips on a support substrate via solder with the substrate side down;  and heating these so that the first metal film 105 is retained in a film and the second metal film 106 is melted into the solder.
Patent JP-S637559-B2 (JP)
IPC: C07H19/10
Filed: 1981-09-09
Abstract: 1- beta -D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil-5'-phosphates of the formula (I):   <IMAGE> (I)  and wherein X is halogen, pharmaceutically acceptable salts thereof, are produced by phosphorylation of the non-phosphorylated precursors of the compounds (I), and are useful as anti-viral agents.
Patent JP-3478850-B2 (JP)
IPC: A61L27/44
Filed: 1993-05-10
Granted: 2003-12-15
Abstract: A composite stem (12) for a prosthesis (10), particularly a hip prosthesis, including a metal core (13) and a fiber reinforced composite shell (14) surrounding the core to provide modules values that are similar to bone. The composite shell is preferably composed of braided fibers and a thermoplastic resin. The stiffness of the prosthesis can be varied along the lenght of the stem.
Patent JP-H0735347-B2 (JP)
IPC: A61K31/22
Filed: 1992-06-11
Abstract: Compounds of formula (I): <IMAGE>  in which:   R represents a hydrogen atom, a linear or branched (C1-C6) acyl radical or a glycoside radical,   n is equal to 1 or 2, R1 and R2 simultaneously represent two hydrogen atoms or, with the double bond to which they are attached, form a phenyl ring.   Medicaments.
Patent JP-3066189-B2 (JP)
IPC: F28D9/00
Filed: 1992-05-19
Granted: 2000-07-17
Abstract: The oil radiator structure (1) particularly for heating rooms comprises a main body (2) which is defined by a plurality of mutually associated radiating elements (3), inside which a hot fluid circulates; each radiating element (3) comprises at least one shaped plate-like element which has heat propagation means suitable for reducing the heat on its outer surface and for simultaneously increasing the efficiency of the radiating element. <IMAGE>
Patent JP-S6246527-B2 (JP)
IPC: C07C13/28
Filed: 1980-12-05
Abstract: Partially hydrogenated oligo-1,4-phenylenes of the formula   <IMAGE> wherein n is 1 or 2, the rings A and B are identical or different and are trans-4-alkylcyclohexyl or 4-alkylcyclohex-1-enyl, and the alkyl groups in each case are of up to 10 carbon atoms, have valuable liquid crystalline properties.
Patent JP-H0510124-B2 (JP)
IPC: B01D39/00
Filed: 1984-09-11
Abstract: A toxic vapour absorptive nonwoven filter material comprising a wet-laid sheet containing fibrillated binder fibre, active carbon in fibre or particle form and submicron diameter glass fibre. The surface of the filter material may by treated with a hydrophobic or an oleophobic agent.
Patent JP-2678496-B2 (JP)
IPC: C08L97/02
Filed: 1989-07-24
Granted: 1997-11-17
Abstract: Compression materials are prepared by compressing substrates with binders which contain polyisocyanates, compounds having at least two hydrogen atoms which are reactive towards isocyanates, alkylene carbonates and, if desired, further additives.
Patent JP-3681793-B2 (JP)
IPC: B65D3/02
Filed: 1995-08-07
Granted: 2005-08-10
Abstract: PROBLEM TO BE SOLVED: To enable a container to be destroyed easily and disposed of without being bulky, by sticking a cut tape, which is incompatible with an injected resin, to at least part of the innermost layer of a blank plate, in a composite container where a blank plate mainly made of paper and a resin are integrated. SOLUTION: One blank plate, mainly made of paper, of which a bottom 1 and body 2 are made are put into a mold, and by injecting a resin to this, a joint 3 between both ends 3a of the blank plate, a gap 4 in the joint between the bottom 1 and body 2, and opening part 5 are filled with the injected resin, and a composite container A is thus molded integrally. A cut tape 7 made of a material which is incompatible with the injected resin, for example a polyester, is thinly stuck to at least part of the inside of the innermost layer of the blank plate. Further, in order to peel off the cut tape 7 easily, notches 8 are made in parts of the blank plate which are adjacent to both sides of a pull 6 temporarily joined with the injected resin. Further, the container is made easily separable by providing the injected-resin part of the opening part 5 with thin parts 10.
Patent JP-2801564-B2 (JP)
Inventor: URDEA MICHAEL S
IPC: C07F9/6561
Filed: 1995-08-07
Granted: 1998-09-21
Abstract: In a method for prepg. oligomers of monomers which include members having common functionalities for condensation, but otherwise differing as to compsn., in which (1) the oligomers are prepd. by sequential addn. of terminally blocked monomers, the monomers having one or more reactive functionalities joined to protective gps., while the growing chain is bound to a support, (2) terminal blocking gps. are removed and the next monomer added and (3) after the final monomer addn., the terminal blocking gp. is cleaved from the support, the improvement comprises (a) prior to each sequential addn., capping terminal gps. which are not blocked with a selectively removable capping gp., (b) after the last monomer addn., removing capping gps. and any enzymatic hydrolysis interfering protecting gps. and (c) enzymatically hydrolysing oligomers lacking a terminal blocking gp., prior to removal of terminal blocking gps.
Patent JP-H0579651-B2 (JP)
Inventor: HANSU KEENE
IPC: A61K9/48
Filed: 1985-09-20
Abstract: 1. Nifedipine-containing hard gelatine capsule, characterized in that the nifedipine is present in molecular dispersion as a solidified melt in a mixture of polyethylene glycols which are liquid and semi-solid at room temperature or polyethylene glycols which are liquid and solid at room temperature or polyethylene glycols which are liquid, semi-solid and solid at room temperature, the ratio of liquid to non-liquid polyethylene glycols being from 7:23 to 23:7, the solidification point of the mixture being between 25 degrees C and 62 degrees C and the mixture having viscosities of 0.1 to 18,000 Pas (1 to 180,000 poise) measured on a mixture of up to 40% by weight of water and polyethylene glycol mixtures at 20 degrees C.
Patent JP-3207540-B2 (JP)
IPC: C08F255/02
Filed: 1992-08-13
Granted: 2001-09-10
Abstract: (I) Ethylene (co)polymerisation is conducted in at least one reaction zone (R) at high pressure, at 150-320 DEG C; (II) The reaction product is routed into a zone (S) at an intermediate pressure P, for separating the molten (co)polymer from the unreacted (co)monomer(s), or the reacted product of the reaction is routed into a 1st zone, or the reaction product is routed into a 1st separating zone (S1) at an intermediate pressure P1; the (co)polymer originating from (S1) is then routed into a 2nd separating zone (S2), at a pressure P2 < P1; (III) the (co)polymer is routed into a zone (SF) at low pressure, for final separation of the (co)polymer from the residual gases. Decompression zones (D), (D1) and (D2) are arranged on the route of the (co)polymer between the zones (S) and (SF), (S1) and (S2), and (S2) and (SF) respectively, grafting monomer(s) being introduced into the line, onto the route of the (co)polymer, at at least one point situated at the zone (D) or at at least one zone (D1, D2). A grafting initiator may be introduced into the line at the same time as the stream of grafting monomer(s), or separately. <IMAGE>
Patent JP-3825181-B2 (JP)
IPC: H01L23/13
Filed: 1998-08-20
Granted: 2006-09-20
Abstract: A semiconductor package includes a semiconductor chip having a major surface and first pads formed on the major surface. The semiconductor package also includes a package substrate having (a) opposite first and second major surfaces, (b) a side surface extending between the first and second major surfaces, (c) a pad forming region adjacent to and along the side surface, (d) second pads formed on the pad forming region, (e) external electrodes formed on the first major surface of the package substrate, wherein the second major surface of the package substrate is fixed to the major surface of the semiconductor chip, and wherein the external electrodes are electrically connected to the second pads. The semiconductor package further includes bonding wires electrically connecting the first pads to the second pads and a sealing material covering the bonding wires and first and second pads.
Patent JP-2675723-B2 (JP)
IPC: C12Q1/68
Filed: 1992-08-14
Granted: 1997-11-12
Abstract: Primers and probes can be used to detect nucleic acid from Mycobacterium in a sample and determine the species from which the nucleic acid originates. The primers amplify regions of the 16S ribosomal RNA gene and hybridize to regions conserved among species. Genus specific probes hybridize to sequences within the amplified region conserved among mycobacterial species, whereas the species specific probes hybridize to a variable region, so that the species identity can be uniquely determined. Consensus probes for detecting mycobacteria nucleic acids are provided which probes are not identical to any of the sequences of mycobacterial species.
Patent JP-H0233531-B2 (JP)
IPC: B60Q1/05
Filed: 1985-12-26
Abstract: PURPOSE:To make fine adjustment for an optical axis ever so easy, by installing a slide member in the crankshaft eccentrically installed in a driving shaft, while rotating the crankshaft solidly with the driving shaft to the extent of an up position from a housing position, and making the crankshaft so as to be displaced at the up position. CONSTITUTION:When a worm gear 4 on a driving shaft 3 is rotated by a motor, a slide member 11 held on a slide guide 10 on a crankshaft 5 being eccentrically supported on this driving shaft 3 is separated of its claw 11h from a notch part 4b, and since an engaging pin 2b of a cover member 2 is engaged with a concave part 11f, its rotation is checked. And, the crankshaft 5 performs circular motion along a vertical surface in the axial direction with rotation of the said gear 4 according to its eccentric quantity, whereby the slide member 11 performs the rotational motion in a small angle with the engaging pin 2b as a fulcrum, so that a crank 6 moves in both directions. In consequence, a position of a pin 7 is varied, and a headlight comes to be altered of its sense of vertical directions inevitably.
Patent JP-3169603-B2 (JP)
IPC: G03B21/62
Filed: 1990-11-30
Granted: 2001-05-28
Abstract: PURPOSE:To execute the shielding or the semi-transmission of the leakage of light projected from a projector and to make a gap between screens inconspicuous by inserting a band-like light shielding member in a gap along the almost central side of total four sheets and shielding the projected light leaked from the gap between the sheets. CONSTITUTION:The fine band-like light shielding member 15 is inserted in the central small gap where total four sheets of two-layered sheets 2 and 3 and the adjacent two-layered sheets 12 and 13 are closely brought into contact one another. Due to that, the gap between the end surfaces of the respective sheets 2, 3, 12 and 13 constituting a multi-screen and the adjacent sheets need not be buried by the light shielding member extending over the whole surface. As the result, since the expansion of the respective sheets 2, 3, 12 and 13 can be executed almost without resistance, the screen is not expanded and the light shielding member is not swollen. Besides, a fine view is not spoiled, optical performance is not deteriorated and the gap between the screens is made inconspicuous. Thus, the gap between the sheets constituting the multi-screen is made inconspicuous.
Patent JP-2754092-B2 (JP)
IPC: A61K6/893
Filed: 1990-11-20
Granted: 1998-05-20
Abstract: A system for crown and root reconstitution comprises a physiological dental securing peg (1) of composite material and a crown reconstituting material (3) placed between the peg (1) and the sound dentine walls (2a), the peg (1) being made of high strength fibres (5) embedded in a resin (4). To improve the physical behaviour of the peg, its fibres (5) are laid axially in the peg (1), are continuous from one end to the other, and are equally tensioned so that the mechanical properties of the peg so obtained are close to those of the dentine in the case of transverse modulus of elasticity and better than those of the dentine in the case of longitudinal compression-tensile strength and shear strength.
Patent JP-2716553-B2 (JP)
IPC: A61K31/495
Filed: 1989-06-21
Granted: 1998-02-18
Abstract: PCT No. PCT/EP89/00694 Sec. 371 Date Jan. 8, 1991 Sec. 102(e) Date Aug. 1, 1991 PCT Filed Jun. 21, 1989 PCT Pub. No. WO90/00553 PCT Pub. Date Jan. 25, 1990.A solid rifapentine hydrohalide useful for anti-bacterial purposes.
Patent JP-H0692348-B2 (JP)
Inventor: ROSINI SERGIO
IPC: A61K31/421
Filed: 1992-04-21
Abstract: PCT No. PCT/EP92/00881 Sec. 371 Date Dec. 30, 1992 Sec. 102(e) Date Dec. 30, 1992 PCT Filed Apr. 21, 1992 PCT Pub. No. WO92/19584 PCT Pub. Date Nov. 12, 1992.This application describes 3-arylalkyl esters of 4,5-dihydro-9,10-dioxo-2-anthracenecarboxylic acid and a process for making them. Also described is a method of using the compounds in the treatment of arthritis.
Patent JP-3259963-B2 (JP)
IPC: C07K14/79
Filed: 1996-08-30
Granted: 2002-02-25
Abstract: The invention related to a GPI-anchored p97 and a soluble form of p97 and derivatives thereof and methods for preparing the same. Methods of using p97 in modulating iron transport, in the delivery of therapeutic agents, and in the treatment of conditions involving disturbances in iron metabolism are described. The treatment and diagnosis of Alzheimer's Disease in view of the finding that p97 and transferrin receptor are markers for microglial cells associated with senile plaques are also described.
Patent JP-3755893-B2 (JP)
IPC: B29L31/56
Filed: 1995-09-15
Granted: 2006-03-15
Abstract: PCT No. PCT/EP95/03644 Sec. 371 Date May 13, 1996 Sec. 102(e) Date May 13, 1996 PCT Filed Sep. 15, 1995 PCT Pub. No. WO96/09153 PCT Pub. Date Mar. 28, 1996Apparatus for manufacturing items made of plastics, particularly screw caps, by pressure molding, which includes a carousel on which molding units are arranged, each molding unit comprising an upper plunger against which a half-mold is hydraulically pushed. The half-mold defines a cavity inside which a dose of plastics has been introduced. Separation elements for extracting the cap after its manufacture are associated with the plunger.
Patent JP-3566963-B2 (JP)
IPC: A61F2/07
Filed: 1994-10-20
Granted: 2004-09-15
Abstract: A delivery system (10) for implantation of a self-expanding stent (17) in a vessel that consists of an elongate flexible catheter (12) for delivering a self-expanding stent (17) to a predetermined location in a vessel. The stent (17) surrounds the flexible catheter (12) near its distal end and is held in a delivery configuration where the stent has a reduced radius along its entire axial length by a stent retaining and release system. The stent retaining and release system is either one or more slipping sleeves which either contain the stent (17) themselves or form a waterproof chamber with the stent being contained by water soluble bands or swelling bands. The stent retaining and release system can also be a pair of sleeves connected to hydraulic pistons, or a pair of sleeves connected to push/pull wires.
Patent JP-4761409-B2 (JP)
IPC: C12N5/10
Filed: 1996-09-23
Granted: 2011-08-31
Abstract: The present invention relates generally to methods for treating injury or degeneration of basal forebrain cholinergic neurons by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating Alzheimer's disease.
Patent JP-2962576-B2 (JP)
IPC: G07D5/00
Filed: 1990-10-15
Granted: 1999-10-12
Abstract: A method of validating coins involves taking two independent measurements of the tested item, and determining whether both measurements lie within respective ranges for a particular coin type, the range for at least one of the measurements being dependent upon at least one other measurement. <IMAGE>
Patent JP-3819934-B2 (JP)
IPC: A61P11/00
Filed: 1994-12-13
Granted: 2006-09-13
Abstract: Compounds of formula I    <IMAGE>  (I)  wherein Q1, Q2, Q3, and Q4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of neurokinin A and useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
Patent JP-3561883-B2 (JP)
IPC: B65D30/24
Filed: 1995-05-10
Granted: 2004-09-02
Abstract: A valve bag is provided having a self-closing feature, to preclude sifting losses after filling, but before the bag is fully sealed, while enabling the facilitated final secure closure of the bag.